tiprankstipranks
Aurubis AG (DE:NDA)
XETRA:NDA
Want to see DE:NDA full AI Analyst Report?

Aurubis (NDA) AI Stock Analysis

45 Followers

Top Page

DE:NDA

Aurubis

(XETRA:NDA)

Select Model
Select Model
Select Model
Neutral 66 (OpenAI - 5.2)
Rating:66Neutral
Price Target:
€188.00
▲(5.09% Upside)
Action:Downgraded
Date:08/10/26
The score is primarily supported by strong financial positioning (low leverage and improved TTM profitability) and a relatively low P/E valuation. Offsetting these positives are weak cash conversion with negative free cash flow and unfavorable technicals, with the stock trading below key moving averages and showing subdued momentum.
Positive Factors
Revenue and Profitability Rebound
The TTM rebound indicates stronger operating performance and renewed earnings capacity. If sustained, improved revenue and margins can support reinvestment and strengthen Aurubis’s position across the copper processing value chain.
Negative Factors
Weak and Inconsistent Cash Conversion
Reported earnings have not translated reliably into cash, limiting internally funded investment and shareholder returns. Recurring negative free cash flow suggests working-capital, capital-expenditure or operating demands may remain a durable constraint.
Read all positive and negative factors
Positive Factors
Negative Factors
Revenue and Profitability Rebound
The TTM rebound indicates stronger operating performance and renewed earnings capacity. If sustained, improved revenue and margins can support reinvestment and strengthen Aurubis’s position across the copper processing value chain.
Read all positive factors

Aurubis (NDA) vs. iShares MSCI Germany ETF (EWG)

Aurubis Business Overview & Revenue Model

Company Description
Headquartered in Hamburg, Germany, Aurubis AG specializes in the advanced processing of metal concentrates and diverse recycling materials. The company's operations leverage a broad array of inputs, encompassing various scrap metals, both organic ...
How the Company Makes Money
Aurubis makes money mainly by processing copper concentrates and recycling materials into saleable metals and metal products, earning revenue from (1) sales of copper products and (2) processing-related income plus (3) sales of by-products and rec...

Aurubis Financial Statement Overview

Summary
Income statement shows a solid TTM rebound (revenue +9.0% and improved profitability, with net margin ~4.5% and EBIT margin ~6.0%). The balance sheet is a major strength with conservative leverage (debt-to-equity ~0.13 TTM) and strong recent ROE (~18.1%). The key drag is weak cash quality: operating cash flow is low versus net income (~0.09) and free cash flow is negative (about -€256M TTM), indicating poor cash conversion despite stronger reported earnings.
Income Statement
78
Positive
Balance Sheet
86
Very Positive
Cash Flow
48
Neutral
BreakdownTTMSep 2025Sep 2024Sep 2023Sep 2022Sep 2021
Income Statement
Total Revenue22.16B18.17B17.14B17.11B18.52B16.37B
Gross Profit1.55B996.00M1.67B1.09B1.81B1.91B
EBITDA1.60B981.00M770.86M372.10M1.12B1.04B
Net Income996.00M539.00M416.10M140.93M714.67M612.80M
Balance Sheet
Total Assets10.88B8.97B7.85B7.26B7.45B6.61B
Cash, Cash Equivalents and Short-Term Investments53.00M355.00M364.21M609.72M766.37M974.65M
Total Debt739.00M541.00M383.22M262.67M327.50M581.31M
Total Liabilities4.96B3.96B3.29B3.01B3.19B3.17B
Stockholders Equity5.91B5.01B4.55B4.24B4.26B3.44B
Cash Flow
Free Cash Flow-256.00M-83.00M-309.20M-52.28M-59.23M559.64M
Operating Cash Flow289.00M675.00M537.47M572.71M287.82M812.08M
Investing Cash Flow-538.00M-769.00M-725.82M-609.70M-201.26M-232.06M
Financing Cash Flow181.00M91.00M17.20M-174.52M-347.17M-95.95M

Aurubis Technical Analysis

Technical Analysis Sentiment
Negative
Last Price178.90
Price Trends
50DMA
180.41
Negative
100DMA
185.15
Negative
200DMA
162.40
Positive
Market Momentum
MACD
-3.18
Positive
RSI
39.19
Neutral
STOCH
10.76
Positive
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For DE:NDA, the sentiment is Negative. The current price of 178.9 is above the 20-day moving average (MA) of 176.65, below the 50-day MA of 180.41, and above the 200-day MA of 162.40, indicating a neutral trend. The MACD of -3.18 indicates Positive momentum. The RSI at 39.19 is Neutral, neither overbought nor oversold. The STOCH value of 10.76 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for DE:NDA.

Aurubis Peers Comparison

Overall Rating
UnderperformOutperform
Sector (55)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
70
Neutral
€45.08B7.6617.00%5.16%-8.88%1431.12%
66
Neutral
€7.44B7.4618.09%0.89%23.24%61.71%
64
Neutral
€2.83B14.9413.75%3.43%5.76%2.14%
62
Neutral
€8.76B24.068.30%3.22%-5.28%-13.76%
55
Neutral
$6.65B3.83-15.92%6.20%10.91%7.18%
52
Neutral
€1.08B-0.2564.53%
* General Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
DE:NDA
Aurubis
172.80
77.50
81.32%
DE:BAS
BASF SE
51.79
5.64
12.22%
DE:B5A0
Bauer AG
5.92
-0.33
-5.28%
DE:BYW
BayWa AG
9.20
0.48
5.57%
DE:GBF
Bilfinger
74.30
-14.27
-16.11%
DE:BNR
Brenntag AG
61.68
8.92
16.91%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Aug 10, 2026